36 Ergebnisse für: lhon
-
The Science of LHON from the Patient Perspective - 2015 LHON Conference - YouTube
https://www.youtube.com/watch?v=d49lMT8kUjQ
Dr. Alfredo Sadun, Dr. Valerio Carelli and Dr. Patrick Yu-Wai-Man answer questions about LHON from the patient perspective.
-
Hereditäre Netzhautdystrophien
http://retinascience.de/ausgabe/index.php?nav=info&S_ID_1=066#S066
Infos für Patienten rund ums Auge, Fortbildungsangebote für Augenärzte, wissenschaftliche Betreuung
-
2014 LHON Conference - Part 9 "Developing the Global LHON Community" - YouTube
https://www.youtube.com/watch?v=YuBt8oakXUM
Keine Beschreibung vorhanden.
-
2014 LHON Conference - Part 3 "What Triggers Vision Loss in LHON?" - YouTube
https://www.youtube.com/watch?v=lUgoDWhSBHQ
Valerio Carelli, MD, PhD
-
Lebersche Hereditäre Optikus-Neuropathie
https://www.ukaachen.de/kliniken-institute/klinik-fuer-augenheilkunde/fuer-patienten/erkrankungen-und-therapien/lebersche-heredi
Keine Beschreibung vorhanden.
-
Lebersche Hereditäre Optikus-Neuropathie
https://www.ukaachen.de/kliniken-institute/klinik-fuer-augenheilkunde/fuer-patienten/erkrankungen-und-therapien/lebersche-hereditaere-optikus-neuropathie.html
Keine Beschreibung vorhanden.
-
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?mid=19&vid=&lang=en
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201510&newsid=1955888&newslang=en
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.
-
Pharmaceutical Company: Medicine Research & Development | Santhera Pharmaceuticals Switzerland
http://www.santhera.com/index.php?docid=212&vid=&lang=en&newsdate=201509&newsid=1950678&newslang=en
Pharmaceutical company in Switzerland committed to research & development of medicines for patients living with mitochondrial disorders & rare diseases.